Pharmacology & ToxicologybioRxivPreprint
Increased utrophin expression in healthy and DMD patient derived myoblasts in response to ERK1/2 and EZH2 inhibitor treatment
Hannah J. Gleneadie, Thomas Francis, Stephanie P L Mo…·Amanda G. Fisher
The paper shows that ERK1/2 and EZH2 inhibitors increase utrophin expression in myoblasts from healthy and DMD patients, with sustained effects in patient-derived cells.
DOI 10.64898/2026.04.13.718206